FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293056571> ?p ?o ?g. }

• W4293056571 abstract "This study aims to identify the roles of exo-β-glucan (EPS-BG) and endo-β-glucan (ENS-BG) extracted from Ganoderma lucidum (GL) in inhibiting the alpha-glucosidase enzyme, a target mechanism for postprandial hyperglycaemia regulation. Upscale production of GL was carried out using a 10 L bioreactor. The zebrafish embryo toxicity test (ZFET) was carried out based on OECD guidelines. The hatching rate, survival rate, heart rate, morphological malformation, and teratogenic defects were observed and determined every 24 h from 0–120 h of post-exposure (hpe). For diabetes induction, adult zebrafish (3–4 months of age) were overfed and induced with three doses of 350 mg/kg streptozotocin (STZ) by intraperitoneal injection (IP) on three different days (days 1, 3, and 5). The oral sucrose tolerance test (OSTT) and anti-diabetic activity of EPS-BG and ENS-BG were evaluated (day 7) using the developed model ( n = 15). This study showed that EPS is the most potent compound with the highest inhibitory effect toward the alpha-glucosidase enzyme with an IC 50 value of 0.1575 mg/ml compared to ENS extracts (IC 50 = 0.3479 mg/ml). Both EPS-BG and ENS-BG demonstrated a strong inhibition of alpha-glucosidase activity similar to the clinically approved alpha-glucosidase inhibitor, acarbose (IC 50 = 0.8107 mg/ml). ENS-BG is non-toxic toward zebrafish embryos with LC 50 of 0.92 mg/ml and showed no significant changes in ZE hatching and normal heart rate as compared to untreated embryos (161 beats/min). Teratogenic effects of ENS-BG (&lt;1.0 mg/ml) on zebrafish embryonic development were not observed. The DM model of zebrafish was acquired after the third dose of STZ with a fasting BGL of 8.98 ± 0.28 mmol/L compared to the normal healthy group (4.23 ± 0.62 mmol/L). The BGL of DM zebrafish after 30 min treated with EPS-BG and ENS-BG showed a significant reduction ( p &lt; 0.0001). Both EPS-BG and ENS-BG significantly reduced DM zebrafish’s peak blood glucose and the area under the curve (AUC) in OSTT. Hence, EPS-BG and ENS-BG extracted from GL showed promising inhibition of the alpha-glucosidase enzyme and are considered non-toxic in ZE. Moreover, EPS-BG and ENS-BG reduced blood glucose levels and inhibited hyperglycemia in DM zebrafish." @default.
• W4293056571 created "2022-08-25" @default.
• W4293056571 creator A5002402361 @default.
• W4293056571 creator A5027438002 @default.
• W4293056571 creator A5059884384 @default.
• W4293056571 creator A5067581583 @default.
• W4293056571 creator A5083118283 @default.
• W4293056571 date "2022-08-25" @default.
• W4293056571 modified "2023-09-25" @default.
• W4293056571 title "Bioreactor-grown exo- and endo-β-glucan from Malaysian Ganoderma lucidum: An in vitro and in vivo study for potential antidiabetic treatment" @default.
• W4293056571 cites W1014546871 @default.
• W4293056571 cites W1268815675 @default.
• W4293056571 cites W1979077733 @default.
• W4293056571 cites W1989706239 @default.
• W4293056571 cites W2011468453 @default.
• W4293056571 cites W2027956912 @default.
• W4293056571 cites W2048045934 @default.
• W4293056571 cites W2050216788 @default.
• W4293056571 cites W2055024943 @default.
• W4293056571 cites W2094930530 @default.
• W4293056571 cites W2131643610 @default.
• W4293056571 cites W2141438284 @default.
• W4293056571 cites W2148989249 @default.
• W4293056571 cites W2153002689 @default.
• W4293056571 cites W2160571689 @default.
• W4293056571 cites W2191636318 @default.
• W4293056571 cites W2279685757 @default.
• W4293056571 cites W2399500481 @default.
• W4293056571 cites W2496713050 @default.
• W4293056571 cites W2581920297 @default.
• W4293056571 cites W2586162900 @default.
• W4293056571 cites W2604915055 @default.
• W4293056571 cites W2609400275 @default.
• W4293056571 cites W2614715581 @default.
• W4293056571 cites W2616831853 @default.
• W4293056571 cites W2754960602 @default.
• W4293056571 cites W2755697592 @default.
• W4293056571 cites W2764120007 @default.
• W4293056571 cites W2799926029 @default.
• W4293056571 cites W2805141005 @default.
• W4293056571 cites W2806656005 @default.
• W4293056571 cites W2883665668 @default.
• W4293056571 cites W2887972508 @default.
• W4293056571 cites W2893772748 @default.
• W4293056571 cites W2917130998 @default.
• W4293056571 cites W2940163147 @default.
• W4293056571 cites W2945214465 @default.
• W4293056571 cites W2947478023 @default.
• W4293056571 cites W2963810420 @default.
• W4293056571 cites W2964854018 @default.
• W4293056571 cites W2970377320 @default.
• W4293056571 cites W2972148293 @default.
• W4293056571 cites W2986895349 @default.
• W4293056571 cites W2990514922 @default.
• W4293056571 cites W2991270193 @default.
• W4293056571 cites W3015551387 @default.
• W4293056571 cites W3093579209 @default.
• W4293056571 cites W3127483670 @default.
• W4293056571 cites W3136674077 @default.
• W4293056571 cites W3152728916 @default.
• W4293056571 cites W3165339967 @default.
• W4293056571 cites W316595173 @default.
• W4293056571 cites W3189537090 @default.
• W4293056571 cites W3192791713 @default.
• W4293056571 cites W3195243445 @default.
• W4293056571 cites W4200090767 @default.
• W4293056571 doi "https://doi.org/10.3389/fbioe.2022.960320" @default.
• W4293056571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36091430" @default.
• W4293056571 hasPublicationYear "2022" @default.
• W4293056571 type Work @default.
• W4293056571 citedByCount "3" @default.
• W4293056571 countsByYear W42930565712023 @default.
• W4293056571 crossrefType "journal-article" @default.
• W4293056571 hasAuthorship W4293056571A5002402361 @default.
• W4293056571 hasAuthorship W4293056571A5027438002 @default.
• W4293056571 hasAuthorship W4293056571A5059884384 @default.
• W4293056571 hasAuthorship W4293056571A5067581583 @default.
• W4293056571 hasAuthorship W4293056571A5083118283 @default.
• W4293056571 hasBestOaLocation W42930565711 @default.
• W4293056571 hasConcept C126322002 @default.
• W4293056571 hasConcept C150903083 @default.
• W4293056571 hasConcept C181199279 @default.
• W4293056571 hasConcept C185592680 @default.
• W4293056571 hasConcept C207001950 @default.
• W4293056571 hasConcept C2776617576 @default.
• W4293056571 hasConcept C2777832050 @default.
• W4293056571 hasConcept C29730261 @default.
• W4293056571 hasConcept C55493867 @default.
• W4293056571 hasConcept C71924100 @default.
• W4293056571 hasConcept C86803240 @default.
• W4293056571 hasConcept C98274493 @default.
• W4293056571 hasConceptScore W4293056571C126322002 @default.
• W4293056571 hasConceptScore W4293056571C150903083 @default.
• W4293056571 hasConceptScore W4293056571C181199279 @default.
• W4293056571 hasConceptScore W4293056571C185592680 @default.
• W4293056571 hasConceptScore W4293056571C207001950 @default.
• W4293056571 hasConceptScore W4293056571C2776617576 @default.
• W4293056571 hasConceptScore W4293056571C2777832050 @default.
• W4293056571 hasConceptScore W4293056571C29730261 @default.
• W4293056571 hasConceptScore W4293056571C55493867 @default.

• next